AMED:NSD-Amedisys Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 160.38

Change

+3.59 (+2.29)%

Market Cap

USD 5.12B

Volume

0.70M

Avg Analyst Target

USD 227.46 (+41.83%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-18 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

-0.36 (-0.63%)

USD5.11B 47.80 14.77
LHCG LHC Group Inc

+1.42 (+0.98%)

USD4.60B 38.97 17.99
ENSG The Ensign Group Inc

+0.90 (+1.24%)

USD4.02B 21.87 16.52
SGRY Surgery Partners Inc

+0.96 (+2.34%)

USD3.38B 63.00 17.30
AMEH Apollo Medical Holdings Inc

+0.54 (+0.76%)

USD3.18B 55.98 15.73
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
HCSG Healthcare Services Group Inc

+0.31 (+1.36%)

USD1.70B 19.11 11.56
CMPS COMPASS Pathways plc

-0.60 (-1.86%)

USD1.34B N/A N/A
AVAH Aveanna Healthcare Holdings In..

-0.26 (-3.86%)

USD1.24B N/A 11.28
ADUS Addus HomeCare Corporation

N/A

USD1.23B 32.35 18.86

ETFs Containing AMED

Symbol Name Weight Mer Price(Change) Market Cap
RWM ProShares Short Russell20.. 0.00 % 0.95 %

N/A

USD0.30B
SRTY ProShares Trust - ProShar.. 0.00 % 0.95 %

+0.01 (+0.11%)

USD0.11B
TWM ProShares UltraShort Russ.. 0.00 % 0.95 %

-0.01 (-0.08%)

USD0.07B
TZA Direxion Daily Small Cap .. 0.00 % 1.10 %

+0.03 (+0.11%)

USD0.36B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -45.32% 10% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.32% 10% F 10% F
Trailing 12 Months  
Capital Gain -34.81% 14% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.81% 14% F 11% F
Trailing 5 Years  
Capital Gain 253.53% 62% D- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 253.53% 62% D- 85% B
Average Annual (5 Year Horizon)  
Capital Gain 54.28% 76% C 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.28% 76% C 86% B
Risk Return Profile  
Volatility (Standard Deviation) 41.29% 71% C- 44% F
Risk Adjusted Return 131.47% 95% A 97% A+
Market Capitalization 5.12B 100% A+ 86% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 21.05 69% D+ 42% F
Price/Book Ratio 5.15 39% F 27% F
Price / Cash Flow Ratio 17.71 22% F 24% F
EV/EBITDA 12.27 72% C- 56% F
Management Effectiveness  
Return on Equity 31.15% 91% A- 93% A
Return on Invested Capital 20.73% 87% B+ 90% A-
Return on Assets 10.31% 100% A+ 93% A
Debt to Equity Ratio 25.23% 53% F 54% F
Technical Ratios  
Short Ratio 1.99 78% C+ 64% D
Short Percent 2.17% 74% C 57% F
Beta 0.60 65% D 82% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector